Expert Interviews

A 7460% increase in pediatric inhalation exposures since 2016 highlights the need for child-resistant designs and updated parental guidance.

Linda Stein Gold, MD, discusses the promising safety and efficacy of tapinarof cream, 1%, as a nonsteroidal treatment for pediatric patients with atopic dermatitis.

Jennifer Hoffmann, MD, MS, discusses the high rates of overtriage in children with behavioral health symptoms and the need for more objective triage tools.

Margeaux Naughton, MD, discusses the Pediatric Psychiatry Colocalized Consult Clinic model, a strategic approach to improve mental health access and provider training.

Ashley Shoemaker, MD, MSci, discusses the evolving clinical pathways for managing rare genetic and acquired hypothalamic obesity in pediatric patients.

The FDA approval of setmelanotide for patients 4 years and older offers a targeted therapy to address the underlying biology of acquired hypothalamic obesity.

Clinical and family goals should guide the selection between high-dose CIMT and bimanual therapy.

Shara Bialo, MD, explains why immunologic screening for islet autoantibodies is essential to identifying type 1 diabetes in its presymptomatic stages.

Palynziq provides a significant new genotype-independent therapy for patients 12 years and older to help manage and reduce blood phenylalanine levels.

Chad Wells, PhD, shares evidence-based strategies to improve MenACWY 2-dose series completion and address racial and socioeconomic disparities in vaccination.

Kathleen Adelgais, MD, MPH, highlights the critical role of family-centered protocols in overcoming readiness barriers and improving emergency outcomes for children.

A first-of-its-kind approval for hypothalamic obesity offers earlier, targeted treatment in children.

Kathleen Adelgais, MD, MPH, discusses how pediatric emergency care coordinators and family-centered protocols improve emergency outcomes for children.

Aristides Maniatis, MD, FAAP explains how Sogroya reduces treatment burden and improves adherence for pediatric patients with growth disorders.

Pediatricians can use brief dietary screenings and policy advocacy to help families transition from ultra-processed foods toward minimally processed alternatives.

A study found that high consumption of ultra-processed foods in early childhood is associated with increased risks of anxiety, hyperactivity, and aggression.

Kara Margolis, MD, highlights how early life stress influences gastrointestinal health through the gut-brain axis.

A study found that prompt blood sugar control following a gestational diabetes diagnosis can reduce a child's risk of obesity.

Daniel Jaechul Ahn, MD, BS, explains how status exceptions are used to navigate the current 3-status system and why policy reform is necessary.

Researchers have found that reducing parental stress improves parenting behaviors and lowers obesity rates in children.

Children with Crohn disease had reduced microbial diversity and increased proinflammatory bacteria vs peers with disorders of brain-gut interaction.

Mariana Bueno, PhD, RN, discusses the physiological considerations, clinical barriers, and best practices for effectively using sucrose to mitigate procedural pain in infants.

A small dose of sucrose administered before painful hospital procedures is a simple and rapid method for reducing pain in newborns.

Clesrovimab has been shown to maintain RSV-protection in infants across 2 RSV seasons, while also having positive safety data.

Clinical trial data demonstrate that clesrovimab maintains a safety profile comparable to palivizumab while providing significant protection against RSV-related infections.

Brian Schroer, MD, highlights recent data exploring the origins of EoE inflammation and the efficacy and limitations of recent biologic treatments.

Carissa Baker-Smith, MD, MPH, outlines practical office-based interventions to help pediatricians effectively manage youth cardiovascular risk factors.

Carissa M. Baker-Smithm MD, MPH, outlines how pediatricians can mitigate long-term cardiovascular risk.

Hao Zhang, PhD, MPH, and Biaskha “Pia” Sen, PHD, discuss factors contributing to the rise in pediatric diabetes rates.

David Fleischer, MD, discusses how the VITESSE trial positions the VIASKIN peanut patch as a promising option for children with peanut allergy.